Cresco Labs Inc.
CL
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 655.85M | 670.20M | 685.07M | 705.90M | 724.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 655.85M | 670.20M | 685.07M | 705.90M | 724.34M |
| Cost of Revenue | 331.28M | 344.93M | 345.72M | 354.93M | 359.89M |
| Gross Profit | 324.57M | 325.27M | 339.35M | 350.97M | 364.45M |
| SG&A Expenses | 227.28M | 226.01M | 231.55M | 235.43M | 233.07M |
| Depreciation & Amortization | 20.18M | 20.67M | 20.74M | 21.50M | 21.77M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 578.73M | 591.61M | 598.01M | 611.86M | 614.73M |
| Operating Income | 77.11M | 78.60M | 87.07M | 94.04M | 109.61M |
| Income Before Tax | -95.42M | -5.22M | 16.20M | -27.48M | -10.62M |
| Income Tax Expenses | 44.62M | 45.44M | 52.59M | 46.19M | 49.87M |
| Earnings from Continuing Operations | -140.04 | -50.66 | -36.38 | -73.67 | -60.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.64M | -1.54M | -9.30M | -10.01M | -13.95M |
| Net Income | -135.41M | -52.19M | -45.68M | -83.68M | -74.44M |
| EBIT | 77.11M | 78.60M | 87.07M | 94.04M | 109.61M |
| EBITDA | 125.83M | 130.45M | 141.00M | 150.71M | 168.71M |
| EPS Basic | -0.38 | -0.15 | -0.13 | -0.24 | -0.22 |
| Normalized Basic EPS | 0.07 | 0.04 | 0.03 | -0.07 | -0.05 |
| EPS Diluted | -0.38 | -0.15 | -0.13 | -0.24 | -0.22 |
| Normalized Diluted EPS | 0.07 | 0.04 | 0.03 | -0.07 | -0.05 |
| Average Basic Shares Outstanding | 1.42B | 1.41B | 1.40B | 1.39B | 1.38B |
| Average Diluted Shares Outstanding | 1.42B | 1.41B | 1.40B | 1.39B | 1.38B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |